SCHEMBL336373

SCHEMBL336373

CCCCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(=O)CCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
MAPT P10636 2/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 1/20 0.46
PAM P19021 2/20 0.46
KDM4E B2RXH2 1/20 0.45
DUSP3 P51452 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPK1 P28482 1/20 0.45
TSHR P16473 2/20 0.44
PRKCA P17252 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCD Q05655 1/20 0.43
DNM1 Q05193 1/20 0.42
CYP3A4 P08684 1/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
P2RY10 O00398 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL346382 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL336371 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL2482147 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL6927476 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL336490 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL15648440 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL192213 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL318615 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL346381 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM
SCHEMBL28246076 1.00 DGKA (0.50) DGKAMAPTLMNAALDH1A1PAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 951 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120022196-A Composite powder with directional oil absorption performance and preparation method and application thereof 广州卡迪莲化妆品科技有限公司 2025-05-23 CN claimed
US-12290582-B2 Creamy hydrating cosmetic composition in a water release emulsion L'OREAL (FR) 2025-05-06 US claimed
CN-119792099-A Antibacterial washing and caring cleaning sheet, and preparation method, application method and application thereof 广州洁生日化有限公司 2025-04-11 CN claimed
WO-2025043460-A1 ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2025-03-06 WO claimed
US-20250011570-A1 MARINE BIODEGRADATION PROMOTER HAVING HYDROCARBON GROUP, AND MARINE BIODEGRADABLE COMPOSITION NISSHINBO HOLDINGS INC. (JP) 2025-01-09 US claimed
CN-118973536-A Emulsion moisturizing cosmetic composition in water-releasing emulsion 欧莱雅 2024-11-15 CN claimed
EP-4452189-A1 CREAMY HYDRATING COSMETIC COMPOSITION IN A WATER RELEASE EMULSION RELATED APPLICATIONS L'OREAL (FR) 2024-10-30 EP claimed
EP-4442747-A1 MARINE BIODEGRADATION PROMOTER HAVING HYDROCARBON GROUP, AND MARINE BIODEGRADABLE COMPOSITION Nisshinbo Holdings Inc. (JP) 2024-10-09 EP claimed
CN-118593361-A Surface treatment method for powder, surface treatment agent composition used therein, and surface-treated powder 味之素株式会社 2024-09-06 CN claimed
CN-114423398-B Surface treatment method for powder, surface treatment agent composition used therein, and surface-treated powder 味之素株式会社 2024-07-16 CN claimed
EP-2271677-A1 SHEAR THINNING PEROXIDE DISPERSIONS Arkema Inc. (US) 2011-01-12 EP claimed
US-20100278770-A1 WAX-IN-WATER EMULSION COMPRISING A COMBINATION OF A GLUTAMIC ACID DERIVATIVE AND AN ALKYLPOLYGLYCOSIDE L'OREAL (FR) 2010-11-04 US claimed
CN-101874766-A The water bag wax emulsion that contains the combination of glutamate derivatives and alkyl poly glucoside OREAL 2010-11-03 CN claimed
WO-2009134950-A1 SHEAR THINNING PEROXIDE DISPERSIONS ARKEMA INC. (US) 2009-11-05 WO claimed
EP-0766959-B1 Cosmetic sunscreening compositions containing TiO2 nanopigments and an acrylaminoacid OREAL (FR) 1998-11-25 EP claimed
WO-1997012590-A1 ULTRAVIOLET-PROTECTING COSMETIC COMPOSITIONS CONTAINING TiO2 NANOPIGMENTS AND AN ACYLAMINOACID L'OREAL (FR) 1997-04-10 WO claimed
EP-0766959-A1 Cosmetic sunscreening compositions containing TiO2 nanopigments and an acrylaminoacid L'OREAL (FR) 1997-04-09 EP claimed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
WO-1991012229-A1 PROCESS FOR PREPARING ACYL DERIVATIVES OF ACYLATABLE COMPOUNDS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 1991-08-22 WO claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278770-A1 WAX-IN-WATER EMULSION COMPRISING A COMBINATION OF A GLUTAMIC ACID DERIVATIVE AND AN ALKYLPOLYGLYCOSIDE KRT18, GRIK5, GRIK2 DGKA 332/4885MAPT 1155/4885LMNA 1733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.